Our Collaboration & Partnership Approach
Partnering plays an important role alongside our in-house research and development. Escient is open to collaborations & partnerships with industry and academic institutions to address high unmet medical needs.
We believe therapeutic intervention targeting novel pathways along the neurosensory-immune inflammatory axis, including development of MRGPR-based therapeutics, has broad potential for the treatment of a wide variety of diseases.
Areas of interest include:
- Explorations of MRGPR & GPCR targets beyond our lead programs
- Other targets amenable to small molecule approaches to address high unmet need indications